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Mitochondrial-Targeted Fatty Acid Analog Induces
Apoptosis with Selective Loss of Mitochondrial
Glutathione in Promyelocytic Leukemia Cells
actions [5] with proteins such as the adenine nucleotide
translocator (ANT) and the voltage-dependent anion
channel (VDAC) controlling mitochondrial permeabiliza-
tion [1, 6–9]. In addition, the Bcl-2 protein has been
suggested to function in an antioxidant pathway to pre-
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A˚rstadveien 19 creased generation of reactive oxygen species (ROS)
[12], and is sometimes accompanied by cellular glutathi-N-5009 Bergen
Norway one depletion [13–15]. In accordance, experimental
modulation of cellular thiols has been reported to affect
the cellular resistance to apoptosis [16, 17], supporting
the theory that increased levels of glutathione may beSummary
associated with drug and radiation resistance of malig-
nant cells [11, 18].Some fatty acids and derivatives are known to induce
Mitochondria do not have the ability to produce gluta-cell death in cancer cells. Mitochondria may have im-
thione, which is required for the normal function of theseportant roles in the death process. Therefore, we in-
organelles [11]. The transfer of glutathione from cytosolvestigated the mitochondrial contribution in cell death
into mitochondria is mediated by a multicomponentinduced by a modified fatty acid, tetradecylthioacetic
transport system. This system provides a remarkableacid (TTA), which cannot be-oxidized. TTA treatment
ability of mitochondria to retain glutathione under condi-induced apoptosis in IPC-81 leukemia cells via depo-
tions where the cytosolic level might fall [19]. The mito-larization of the mitochondrial membrane potential
chondrial thiol status has been proposed to constitute() and early release of cytochrome c, accompanied
a critical sensor of the cellular redox potential that is ofby depletion of mitochondrial glutathione. Caspase-3
importance during mitochondrial membrane permeabili-activation and cleavage of poly (ADP-ribose) polymer-
zation and induction of apoptosis [16, 20–22].ase (PARP) occurred at a late stage, but the broad-
The promyelocytic leukaemia cell line IPC-81 under-spectra caspase inhibitor zVAD-fmk did not block
goes rapid and synchronous apoptosis when treatedTTA-induced apoptosis. Overexpression of Bcl-2 par-
with cAMP-elevating agents or cell-permeable cAMPtially prevented TTA-induced apoptosis, whereas
analogs [23]. The cAMP-induced apoptosis occurscAMP-induced cell death was completely blocked. In
through activation of cAMP-dependent kinase, involvingconclusion, TTA seems to trigger apoptosis through
phosphorylation of transcription regulators, protein syn-mitochondrial-mediated mechanisms and selective
thesis and cotranslational phosphorylation [24–26]. IPC-modulation of the mitochondrial redox equilibrium.
81 cells overexpressing Bcl-2 (IPC-81 Bcl-2) or inducible
cAMP early repressor (ICER; IPC-81 ICER) are protected
Introduction against cAMP-induced apoptosis, but IPC-81 Bcl-2 cells
undergo granulocytic differentiation during long-term
Apoptotic stimuli trigger coordinated action of specific exposure to cAMP [25, 27].
cascades involving different organelles and structures, A range of compounds involved in cellular lipid metab-
such as the nucleus, the endoplasmic reticulum, the olism, including saturated and unsaturated fatty acids
mitochondria, and the plasma membrane. The under- and derivatives, induce apoptosis [28–32]. It has been
standing that mitochondria are key organelles in apopto- suggested that cell death induced by long-chain fatty
sis induced by various stimuli has evolved from observa- acids in pancreatic islets is conducted via a lipoapototic
tions of changes in mitochondrial membrane integrity pathway involving ceramide synthesis and NO overpro-
and release of mitochondrial substances, which seem duction [33]. In another system, palmitic acid was found
to be rate limiting for induction of caspases and endonu- to induce apoptosis via a direct effect on mitochondria
cleases [1]. Mitochondrial membrane permeabilization [32]. Fatty acids may cause changes in mitochondrial
is accompanied with depletion of the membrane poten- membrane permeability due to their protonophoric ac-
tial () and release of matrix solutes and intermem- tivity and/or through their interaction with ANT [34–36]
brane proteins, including the apoptosome-activating cy- and other ion transport systems of the inner membrane.
tochrome c [2] and Diablo/SMAC-1 [3, 4]. Members of TTA is a modified saturated fatty acid analog with a
the Bcl-2 family proteins regulate the apoptotic pathway sulfur atom inserted in the 3 position from the carboxylic
involving the mitochondria through protein-protein inter- end (CH3-(CH2)13-S-CH2COOH). The metabolism and
metabolic effects of TTA have been reviewed [37, 38].
This thia-fatty acid is blocked for -oxidation and is*Correspondence: rolf.berge@ikb.uib.no
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therefore catabolized by the -oxidation pathway in en-
doplasmic reticulum and peroxisomes. As a ligand for
members of the peroxisome proliferator-activated re-
ceptor (PPAR) family of nuclear hormone receptors, TTA
regulates expression of fatty acid-metabolizing enzymes,
in particular those of catabolic pathways [37, 39, 40].
Following cellular uptake, TTA is converted to TTA-CoA
[41], which is a substrate for the carnitine palmitoyltrans-
ferase system (CPT I and CPT II) transporting acyl-CoAs
into the mitochondria [37, 42]. TTA stimulates the mito-
chondrial oxidation of normal fatty acids [43] and induces
mitochondrial proliferation in rat hepatocytes [44].
Antiproliferative effects of TTA have been observed
in several cancer cell lines, and circumstantial evidence
for induction of apoptosis has been found [45–48]. In
this study, we compare apoptosis induced by cAMP and
TTA in a myeloid leukemia cell line. Since TTA-induced
apoptosis was partly blocked by Bcl-2 overexpression
and involved early mitochondrial changes, we suggest
that mitochondria participate in the death process.
Results
Induction of Apoptosis after Treatment with TTA
Apoptotic cell surface blebbing was observed in parallel
with chromatin condensation and nuclear fragmentation
in IPC-81 cultures exposed to TTA. Morphological signs
of TTA-induced apoptosis were evident after 12 hr Figure 1. Induction of Apoptosis in Cells Treated with TTA and
8CPT-cAMP(18.6%  10.1%), and the percentage of apoptotic cells
gradually increased until it reached a plateau around 20 Wild-type and Bcl-2-overexpressing IPC-81 cells were treated with
either 500 M BSA-bound TTA (A) or 200 M 8CPT-cAMP (cAMP)hr (67.2%  4.2%) after TTA-addition (Figure 1A). Cells
(B). Apoptosis was determined by microscopic examination of celloverexpressing Bcl-2 were protected from apoptosis at
surface and nuclei after staining with Hoechst 33342. The data areearly stages, but a moderate increase in the apoptotic
presented as mean  SD. *p  0.05 compared to untreated control.
score was observed at later stages (20 and 24 hr). Apo-
ptotic induction by the cell permeable cAMP analog
substrates. TTA induced the activity of caspase-3 in8-chlorophenylthio-cAMP (8CPT-cAMP) in IPC-81 cells
IPC-81 cells (Figure 3A), and this occurred at late stageswas more rapid than with TTA, but it was completely
about simultaneously with the appearance of apoptoticblocked by overexpression of Bcl-2 (Figure 1B).
morphology (Figure 1A). A similar pattern was also ob-
served for 8CPT-cAMP (Figures 3A and 1B). Activation
TTA Triggers Cytochrome c Release of caspase-3 with TTA was supported by a decrease in
It is widely accepted that cytochrome c release is a key the level of the inactive procaspase-3 and cleavage of
event in mitochondrial-mediated apoptosis, leading to the caspase-3 substrate protein poly(ADP-ribose) poly-
activation of executive cascades. In our studies, the merase (PARP), which is a nuclear enzyme that detects
level of cytochrome c in mitochondrial fraction of IPC- and binds DNA strand breaks produced by various
81 cells fell nearly 70% within 6 hr of TTA exposure, apoptotic stimuli (Figure 3B). A marked decrease in the
after which it remained at a low level (Figure 2A). The procaspase-3 level and appearance of the apoptotic 85
level of cytochrome c in the cytosolic fraction increased kDa PARP cleavage product occurred between 12 and
in conformity with the mitochondrial loss (Figure 2B). 18 hr of TTA treatment, simultaneously with the dramatic
The inserted curve in Figure 2B indicates that most of increase in caspase-3 enzyme activity (Figure 3A). In
the cytochrome c was released during the first 3 hr 8CPT-cAMP-treated cells, the level of procaspase-3 de-
of treatment. In comparison, the mitochondrial level of clined simultaneously with elevated caspase-3 activity
cytochrome c in 8CPT-cAMP-treated cells gradually de- and cleavage of PARP (Figure 3B). To decide whether
clined to about 30% after 6 hr of incubation, simultane- caspase activation is essential in the apoptotic execu-
ously with an increasing level in the cytosol (Figures 2C tion, we examined the influence of the broad-spectra
and 2D). Overexpression of Bcl-2 or ICER did not block caspase antagonist zVAD-fmk. After 20 hr of TTA expo-
TTA-induced translocation of cytochrome c, whereas sure, the percentage of cells with apoptotic morphology
the effect of 8CPT-cAMP was absent in these cells (Fig- did not seem to be affected by the presence of zVAD-
ures 2E and 2F). fmk (Figure 3C). However, a lower degree of nuclear
fragmentation was observed in apoptotic cells with con-
The Role of Caspases in TTA-Induced Apoptosis densed chromatin in the presence of zVAD-fmk (Figure
Release of cytochrome c to the cytosol leads to activa- 3D). In contrast, zVAD-fmk efficiently counteracted
8CPT-cAMP-induced apoptosis (Figures 3C and 3D).tion of caspase-3 and, thereby, proteolysis of distinct
TTA-Induced Apoptosis in Leukemia Cells
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Figure 2. Cytochrome c Release
Mitochondrial and cytosolic fractions were isolated from wild-type IPC-81 (wt) cells, and IPC-81 cells overexpressing Bcl-2 or ICER. Cytochrome
c (Cyt c ) was determined as described in Experimental Procedures. Cells were treated with 500 M BSA-bound TTA (A and B) or 200 M
8CPT-cAMP (cAMP) (C and D). The inserted curve in (B) shows the increase of cytosolic cytochrome c at early time points (0.5–4 hr) in TTA-
treated cells. (E and F) Cytochrome c was measured in cytosol and mitochondria from IPC-81 wild-type, IPC-81 Bcl-2, and IPC-81 ICER cells
after 12 and 6 hr of exposure to 500 M TTA and 200 M 8CPT-cAMP, respectively. The data are given as mean  SD. *p  0.05 compared
to untreated control.
Alterations in Mitochondrial Glutathione Status from the cytosolic pool, and it appears to be resistant
to fluctuations in the cytosolic level of glutathione [19].during Apoptosis
Glutathione is a key regulator of the intracellular redox We therefore investigated how the mitochondrial and
cytosolic pools of glutathione were affected during TTA-status, which is an important factor in the control of
cellular homeostasis. Previously, cellular glutathione and 8CPT-cAMP-induced apoptosis.
TTA caused a time-dependent decrease in the mito-depletion has been associated with apoptosis. The mito-
chondrial pool of glutathione is regulated separately chondrial level of glutathione (GSH  GSSG) in IPC-
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Figure 3. The Role of Caspases in 8CPT-cAMP- and TTA-Induced Cell Death
IPC-81 cells were exposed to 500 M BSA-bound TTA or 200 M 8CPT-cAMP (cAMP).
(A) Capase-3 activity was measured in cellular extracts.
(B) The level of procaspase-3 and cleavage pattern of PARP was assessed by Western analysis.
(C) Apoptosis was scored in cultures treated with 8CPT-cAMP (6 hr) or TTA (20 hr) in absence or presence of zVAD-fmk (zVAD).
(D) Morphological changes were visualized by phase contrast (left) and Hoechst fluorescence (right) microscopy. The data are given as mean
SD. ap  0.05 compared to untreated control, bp  0.05 compared to the same treatment (cAMP) in absence of zVAD-fmk.
81 cells (Figure 4A). This was in part due to loss of tion of relevant fluorescent probes by scanning laser
imaging and flow cytometry. Cellular staining by somenonoxidized GSH, leading to a significant decrease in
the GSH/(GSSG  GSH) ratio at late stages (12 and 18 of these probes was obstructed by exogenous bovine
serum albumin (BSA) used for TTA administration, possi-hr) (Figure 4B). The mitochondrial level of glutathione
was kept constant during 8CPT-cAMP treatment (Figure bly due to physical interaction and dye adsorption by
BSA. Hence, TTA was prepared in absence exogenous4C), but there was a slight decrease in GSH (significant
after 6 hr) causing a moderate but significant decrease BSA by binding to culture serum protein. In previous
studies, the exclusion of BSA has been demonstratedin the mitochondrial GSH/(GSSG  GSH) ratio at late
stages (3 and 6 hr) (Figure 4D). to sensitize cells, possibly due to increased cellular up-
take of TTA [46]. Thus, serum-bound TTA at a concentra-More than 90% of the free cellular glutathione was
found in the cytosolic fraction, and the level of GSH  tion of 200 M induced massive nuclear fragmentation
within 6 hr in IPC-81 cells (Figure 5A). The morphologyGSSG was not significantly altered during 18 hr of treat-
ment with TTA (Figure 4E). There was, however, a late of TTA-induced apoptosis was analogous to the classic
apoptotic morphology observed after exposure todecline in GSH (Figure 4E), resulting in a moderate de-
crease in the cytosolic GSH/(GSSG  GSH) ratio at late 8CPT-cAMP (Figure 5B), with chromatin margination
and an extensive formation of micronuclei. Overexpres-stages (12 and 18 hr) (Figure 4F). Neither the level of
glutathione nor the GSH/(GSSG  GSH) ratio in cytosol sion of Bcl-2 partly rescued the cells from TTA-mediated
cell death, confirming the results in Figure 2. Apoptosiswas affected by treatment with 8CPT-cAMP (Figures 4G
and 4H). induced by 8CPT-cAMP was, in contrast, completely
blocked by Bcl-2 overexpression (Figure 5B).
We examined alterations in  by using JC-1 as de-Analysis of Morphology, , and Glutathione
Distribution by Fluorescent Probes scribed in Experimental Procedures. The red fluores-
cence, reflecting -dependent JC-1 aggregation, wasTo obtain further evidence in support of the involvement
of mitochondria and glutathione status during TTA- affected by both TTA- and 8CPT-cAMP treatment,
whereas the green fluorescence remained unchangedinduced apoptosis, we examined uptake and distribu-
TTA-Induced Apoptosis in Leukemia Cells
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Figure 5. Apoptotic Nuclear Morphology in Wild-Type and
Bcl-2-Overexpressing IPC-81 Cells
Cells were treated with 200 M TTA bound to serum protein (A) or
200 M 8CPT-cAMP (B). Cells were fixed in 4% paraformaldehyde
with daunorubicin (5 M), mounted on slides, and examined by laser
scanning confocal microscopy
Figure 4. Modulation of Mitochondrial Glutathione Early in Apo-
revealed a possible relocalization of mitochondria, i.e.,ptosis
from an even to a clustered distribution, in IPC-81 cellsThe content of total free glutathione (GSSGGSH) and nonoxidized
exposed to 8CPT-cAMP, but not TTA. Redistribution offree glutathione (GSH) was determined by HPLC, and the respective
mitochondria in early stages of apoptosis has previouslyGSH/(GSSG  GSH) ratios were calculated in the mitochondrial
(A–D) and cytosolic (E–F) fractions after treatment with 500 M TTA been described [50].
(A, B, E, and F) or 200 M 8CPT-cAMP (cAMP) (C, D, G, and H). We observed possible subcellular alterations toward
The results are presented as mean  SD. *p  0.05 compared to a more heterogeneous distribution of the glutathione-
untreated control.
reactive compound CMFDA during 8CPT-cAMP, and
especially, TTA treatment (Figures 7A and 7C). At late
stages, there was a significant loss of cellular CMFDA
(Figure 6A). The decrease in red fluorescence demon- intensity. The CMFDA distribution was unchanged in
strates that  was depolarized in IPC-81 cells after IPC-Bcl-2 cells exposed to 8CPT-cAMP (Figure 7D);
exposure to TTA and 8CPT-cAMP (Figure 6B). For 8CPT- however, the dye seemed to accumulate in specific in-
cAMP-treated cells, this is consistent with previous ob- tracellular compartments in a fraction of the TTA-treated
servations that the ATP-level decreases rapidly [49]. cells (Figure 7B). These observations are in accordance
Overexpression of Bcl-2 blocked TTA- and 8CPT-cAMP- with changes in the level and distribution of cellular
mediated  depletion completely, as indicated by the glutathione, supporting the data in Figure 4.
sustained level of red fluorescence in treated IPC-Bcl-2
cells (Figure 6C).
The above data were supported by using the Discussion
-dependent probe MTR in combination with the gluta-
thione-reactive dye CMFDA. TTA and 8CPT-cAMP re- The data obtained in the present study were compatible
with the hypothesis that TTA triggers apoptosis via aduced the intensity of MTR in IPC-81 cells, but not in
IPC-81 Bcl-2 cells (Figure 7). Furthermore, MTR staining specific effect on mitochondria. First, the fatty acid ana-
Chemistry & Biology
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fect of TTA. The only manipulation which effectively re-
duced TTA-induced cell death was overexpression of
Bcl-2, an antiapoptotic protein whose mitochondrial ef-
fect is well documented. Moreover, it appears that Bcl-2
prevents the release of apoptogenic factors from iso-
lated mitochondria treated with a saturated fatty acid
[32]. Metabolic effects of TTA have been widely de-
scribed, and mitochondria seem to be central regulators
of TTA-mediated action [37, 43].
We have previously evaluated various methods for
adequate fatty acid administration to cell culture [46].
By changing the method of fatty acid preparation, the
cellular responses may be affected. Cells treated with
TTA in the absence and presence of exogenous BSA
appeared morphologically similar, but there were differ-
ences in dose response and time frame of induction.
These data are in line with previous results showing that
exclusion of exogenous BSA increases the cellular fatty
acid uptake, allowing significant cellular responses at
lower fatty acid concentrations [46].
TTA activates nuclear hormone receptors of the PPAR
family [39, 51], suggesting that functional modulationFigure 6. Depolarization of  after Treatment with TTA and 8CPT-
may occur through transcriptional activity and proteincAMP
synthesis. However, we have recently found that PPAR-Mitochondrial depolarization was determined by flow-cytometric
independent mechanisms seem to predominate in themeasurements after incubation with the -sensitive dye JC-1. Dis-
antiproliferative effects of TTA in glioma cells [47].sipation of  is indicated by a decrease in red fluorescence (590
nm). (A) Presents representative histograms from the flow-cytomet- IPC-81 cells treated with TTA acquired morphologi-
ric analysis. The level of red fluorescence relative to control is pre- cal changes within the definition of apoptosis. Cyto-
sented as mean  SD for wild-type (B) and Bcl-2-overexpressing chrome c release was triggered early (Figure 2) and
(C) IPC-81 cells treated with either 200 M serum protein bound preceded caspase-3 activation and PARP cleavage by
TTA or 200 M 8CPT-cAMP (cAMP). *p  0.05 compared to un-
several hours (Figures 3A and 3B). The relatively latetreated control.
onset of caspase-3 activation may suggest that this
occurs downstream to the commitment stage, which
log induced an early release of cytochrome c accompa- was supported by the minor influence of zVAD-fmk on
nied by a reduction of. Second, TTA caused a specific the percentage of apoptotic cells in cultures exposed to
time-dependent decrease in the mitochondrial level of TTA (Figure 3C). In presence of zVAD-fmk, TTA induced
glutathione leading to a significant decrease in the GSH/ chromatin condensation, but apparently nuclear frag-
(GSSG  GSH) ratio. Caspase-3 activation and PARP mentation was restricted (Figure 3D), proposing that
cleavage were observed after cytochrome c release, and zVAD-fmk-sensitive caspases may participate in the
degradation phase without being crucial for the commit-interestingly, caspase inhibition failed to reduce the ef-
Figure 7. Mitochondrial Localization and
Glutathione Distribution
Cells were labeled with MTR in combination
with CMFDA as described in Experimental
Procedures. The samples were studied by la-
ser scanning confocal microscopy. Red and
green fluorescence indicates mitochondria
and glutathione, respectively. (A) IPC-81 wild-
type, TTA treatment; (B) IPC-81 Bcl-2, TTA
treatment; (C) IPC-81 wild-type, 8CPT-cAMP
treatment; (D) IPC-81 Bcl-2, 8CPT-cAMP
treatment.
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ment. Bcl-2 overexpression significantly reduced the considered. Furthermore, mitochondria seemed to ag-
gregate after 8CPT-cAMP treatment (Figure 6A), andcellular sensitivity to TTA (Figures 1 and 5). The partly
counteracting effect of Bcl-2 overexpression on TTA- similar observations have been reported for other types
of apoptosis [50]. The functional aspects of such organ-induced apoptosis may be explained by subsidiary
involvement of Bcl-2-dependent and Bcl-2-independent elle redistribution remain elusive.
We conclude that TTA induces apoptotic pathway(s)pathways. Another possibility could be that TTA-induced
mechanism(s) exceeds the protective capacity of Bcl-2. involving early mitochondrial alterations, including mod-
ulation of the mitochondrial glutathione status.It is, however, a paradox that cytochrome c release
appeared equally massive in IPC-81 Bcl-2 cells com-
pared to wild-type cells (Figure 2). Significance
It is commonly accepted that oxidative stress may
induce apoptosis, and consequently, impaired cellular Mitochondria have been proposed as targets for anti-
antioxidant status is likely to sensitize cells to oxidative cancer chemotherapy [56]. This is based on the ability
induction of apoptosis. Depletion of cellular glutathione of some compounds that induce mitochondrial per-
may occur during apoptosis, but its importance in cell meabilization to overcome apoptosis resistance in
death remains elusive [52]. It has, however, been pro- cancer cells with protective abnormalities in their apo-
posed that redox disequillibrium consequent to glutathi- ptotic machinery. Accordingly, it was interesting to
one depletion might cause cytochrome c release [53]. observe that TTA treatment gave an early mitochon-
These observations demonstrate that, under some cir- drial response and partly overcame Bcl-2-mediated
cumstances, the cellular level of glutathione seems to apoptosis inhibition. Furthermore, focusing on mito-
be of importance in apoptosis. Furthermore, Bcl-2 was chondrial regulation of apoptosis, the mitochondrial
found to block apoptosis through nuclear glutathione redox status has been proposed as a contributing fac-
sequestration [54], and manipulative depletion of mito- tor. This understanding is supported by the results
chondrial glutathione sensitized Bcl-2-overexpressing showing that TTA selectively modulates glutathione
HL-60 cells to cyanide m-chlorophenylhydrazone- level and redox status in mitochondria early in the
induced apoptosis [21]. It has also been suggested that induction of apoptosis.
mitochondrial thiols constitute a critical cellular redox
sensor in some apoptotic pathways [16]. Noteworthy, Experimental Procedures
TTA induced depletion of mitochondrial glutathione
Cell Culture and Treatmentearly in the apoptotic process, independent of the cyto-
The IPC-81 cells were grown in Dulbecco’s modified Eagle’s mediumsolic level of glutathione (Figure 4), which suggests that
(DMEM) with 10% heat-inactivated horse serum. Generation anda selective modulation of the mitochondrial redox status
characterization of the transfected IPC-81 Bcl-2 and IPC-81 ICER
may be of importance in TTA-induced apoptosis. Cellu- subclones are described elsewhere [25, 27]. For experimental pur-
lar imaging with CMFDA supported the occurrence of poses, the cells were seeded at a density of 0.4 	 106 cells/ml. The
subcellular redistribution of glutathione during TTA cell-permeable cAMP analog 8CPT-cAMP was used to study cAMP-
mediated effects. TTA was prepared at the Department of Chemis-treatment (Figure 7).
try, University of Bergen, Norway as previously described [57]. TTAMitochondrial permeability transition seems to be reg-
was dissolved in 0.1 M NaOH before addition to horse serum orulated by the redox status of mitochondrial glutathione
essential fatty acid free BSA as described in [46]. The level of apo-
via redox-sensitive sites of ANT [55]. It has been re- ptosis was determined by microscopic cell surface examination
ported that a 3-thia fatty acid (3-thiastearic acid), with and fluorescence analysis after staining with the DNA-specific dyes
a chain length comparable to that of TTA, inhibits ANT daunorubicin (5–10 M) or Hoechst 33342 (10 g/ml) in 4% para-
formaldehyde. Apoptotic cells were easily discriminated from non-activity accompanied by dissipation of  [36]. Hence,
apoptotic cells by the appearance of multiple surface buds, chroma-it is possible that TTA mediates mitochondrial permea-
tin condensation, and nuclear fragmentation. The pan-caspasebilization both directly, e.g., by interacting with ANT,
antagonist zVAD-fmk (BACHEM AG, Bubendorf, Switzerland) was
or indirectly, by modulating mitochondrial glutathione. used at a final concentration of 100 M.
Moreover, TTA was found to uncouple mitochondria in
rat hepatocytes, and the reduction of the proton electro- Preparation of Cellular Fractions
chemical potential (p) was attributed to lowering of  Cell cultures were harvested by centrifugation and washed in PBS
before they were resuspended in a small volume (1–1.5 ml) of Hand not the pH gradient (pH) (our unpublished data).
buffer (50 mM Tris-HCl, 25 mM KCl, 5 mM MgCl2, and 0.25 M sucrose,We therefore suggest that TTA-mediated uncoupling
pH 7.5). The cells were homogenized using a ball-bearing Cell-might involve an electrogenic ion transport system in
Cracker [58] (EMBL, Heidelberg, Germany). Cell debris was removedthe mitochondrial inner membrane, e.g., a metal-ion uni-
by centrifugation at 700 	 g for 10 min (4
C). The resulting suspen-
porter. A candidate could be UCP-2, which was signifi- sion was centrifuged at 13,000 rpm (14,500 	 g) for 15 min (4
C) in
cantly upregulated in the liver of TTA-treated rats; how- a Beckman Optima tabletop ultracentrifuge with TLS-55 swinging
bucket rotor for isolation of mitochondria (pellet). The supernatantever, it is yet to be clarified if UCP-2 can facilitate pH
was centrifuged at 33,000 rpm (93,300 	 g) for 30 min (4
C) forneutral ion transport across the inner membrane.
preparation of cytosolic fraction (supernatant). The protein contentInduction of cell death by cAMP in the leukemia cell
of the fractions was measured with Bio-Rad protein assay (Bio-Radline IPC has been well characterized [49]. In the present
Laboratories, Richmond, CA), using BSA dissolved in distilled water
study, we show that 8CPT-cAMP treatment slightly as standard.
changes the mitochondrial glutathione redox status
without altering the level of total free glutathione. Cytochrome c Immunoassay
Whether this is crucial for 8CPT-cAMP-induced apopto- Cytochrome c was determined using a rat/mouse cytochrome c
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